Apex Clinics Ltd
Apex Clinics Ltd
Advancing men’s health and longevity through evidence-based, data-driven care
Apex Clinics provides personalised, clinically led care for men’s hormonal health, vitality, and wellbeing. Combining diagnostics, hormone therapy, and lifestyle medicine. Apex applies data-driven insights to help patients achieve lasting improvements in energy, longevity, and quality of life.
About Apex Clinics
Apex Clinics delivers advanced men’s health and longevity care by combining medical science, data analytics, and holistic wellbeing practices. The service covers testosterone replacement therapy (TRT), metabolic optimisation, mental wellbeing, and chronic disease prevention.
Apex offers precision diagnostics and evidence-based interventions that empower men to take control of their long-term health and performance.
Growth Highlights
✔ Apex Clinics opened its first site on Wigmore Street, London, in October 2025, marking the beginning of its national rollout.
✔ The clinic has already experienced strong early appointment volumes and patient interest, validating the demand for evidence-based men’s health and longevity care.
✔ The business is now preparing to open additional clinics internationally as part of its broader expansion strategy.
PEAL’s Role
PEAL supported the platform by:
- Supporting the national and international scale-up of Apex Clinics through a hybrid model of physical sites and virtual consultations.
- Strengthening clinical, operational, and technology infrastructure to enable data-driven decision-making and sustainable growth.
- Developing leadership, governance, and commercial capability to position Apex as a leading provider in the men’s health and longevity sector.
PEAL’s Investment Thesis
PEAL chose to invest in Apex Clinics to capitalise on the growing demand for evidence-based men’s health and longevity services. Apex addresses the substantial unmet demand in men’s health – a need further reinforced by Newson’s female patients requesting equivalent services for their partners, confirming Apex’s ability to capture a large and underserved market.